pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›naloxone
drug
save

naloxone

Phase 1updated 5mo ago
by Taho Pharmaceuticals Ltd
Phase 1
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval644 co-mentions · 280 sources
  • drugbuprenorphine ER454 co-mentions · 227 sources
  • drugBUPRENORPHINE HYDROCHLORIDE454 co-mentions · 227 sources
  • drugbuprenorphine454 co-mentions · 227 sources
  • drugBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE454 co-mentions · 227 sources
  • drugSUBLOCADE454 co-mentions · 227 sources
  • drugSUBOXONE454 co-mentions · 227 sources
  • drugBRIXADI454 co-mentions · 227 sources

all catalysts(0)

nothing on the calendar yet

Trials studying naloxone

  • phase1Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adultscompletedn=24
  • phase1Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadonerecruitingn=32
  • phase2A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockadenot yet recruitingn=16
  • phase3Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)active not recruitingn=144
  • phase1Proof of Concept (PoC) Evaluation of Naloxone Unique Intramuscular (IM) Injectioncompletedn=12
  • phase1Pharmacodynamic Evaluation of Intranasal Nalmefenecompletedn=84
  • phase1Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mgcompletedn=24
  • phase1Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).terminatedn=15

News(10)

  • Addiction clinics see rising cases of kratom and 7-OH withdrawal
    Addiction clinics are seeing a surge in patients dependent on potent kratom and 7-OH products.
    stat · 14d ago
  • Why are drug overdose deaths declining?
    Naloxone and harm reduction measures may be helping to curb drug overdose deaths, a new report says.
    stat · 1mo ago
  • Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring
    Two and a half years into his tenure as Emergent BioSolutions CEO, Joseph Papa is executing another round of restructuring to align the business with “current business realities.”
    fiercebiotech · 2mo ago
  • Syphilis spreads while researchers contend with federal constraints and a drug shortage
    At the San Diego-Tijuana border, syphilis spreads while researchers contend with federal constraints and a drug shortage.
    stat · 2mo ago
  • HHS vaccine committee quietly gets new charter
    Lax clinical oversight for online GLP-1 prescriptions, proposed financial help for people who want to quit smoking, and more health news
    stat · 2mo ago
  • Super-potent synthetic opioids called nitazenes are spreading across the U.S.
    Overdose deaths confirmed to involve nitazenes have risen sharply in the U.S., from 27 in 2020 to 409 in 2024, according to the CDC
    stat · 3mo ago
  • Trump administration will bring special ed to HHS
    Infant mortality rate dips, OTC naloxone options rise, and other health news from Morning Rounds
    stat · 3mo ago
  • FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
    The U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergen…
    fda_press · 3mo ago
  • U.S. overdose deaths fell again in 2025, but some worry about policy and drug supply changes
    About 70,000 Americans died of drug overdoses last year — about 14% fewer than the previous year, according to preliminary government data.
    stat · 4mo ago
  • Trump administration’s drug strategy is at odds with recent actions on funding, policy
    The White House nods to medication-assisted treatment and fentanyl test strips, despite recently placing new limits.
    stat · 5mo ago
view all news mentions →
generic
naloxone [INN]
indication
Acute Opioid Overdosage
phase
phase_1
Data sources
ClinicalTrials.gov
last refreshed 5h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?